Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jul 18, 2025
    Data Limitation Disclosures Can Temper Conference Attendees' Perceptions of Promoted Drugs
  • Jun 28, 2025
    Xlear Sues FTC Over Substantiation of Marketing Claims
  • Jun 25, 2025
    Amazon Must Face Suit Alleging That It Marketed Dietary Supplements Without FDA-Required Disclaimers
  • Jun 20, 2025
    Congress Introduces Bills To Ban DTC Drug Ads
  • Jun 14, 2025
    OPDP Warning Letter Alleges Instagram Post Lacked Risk Info
  • May 30, 2025
    Senator Questions FDA’s Commitment to DTC Oversight
  • May 23, 2025
    OPDP Issues First Warning Letter in Nearly Two Years
  • May 21, 2025
    Device Firm CEO Pleads Guilty to Charge of Making False Statements to CMS Regarding Alleged Kickbacks
  • May 20, 2025
    Concerns Over Risk Claims Prompt Untitled Letter for Speaker Deck
  • May 14, 2025
    FDA, HHS Launch Deregulation Initiative, Seek Public Input on Outdated, Unneeded Rules, Guidance
  • More

Good Clinical Practice

  • Jul 6, 2025
    Bill Exempting Trial Payments From Taxes Introduced in House
  • Jun 28, 2025
    Changes Coming for Federal Oversight of Human Research Protections
  • Jun 13, 2025
    Draft ICH Guideline Calls for Paradigm Shift in Enrolling Pregnant and Lactating Women in Clinical Trials
  • Jun 6, 2025
    CBER Issues First 2025 Warning Letter Addressing Clinical Trial Concerns
  • May 25, 2025
    CDRH Sends Sponsor Warning Letter Over Significant Risk Study Concerns
  • May 20, 2025
    OHRP Closes N.Y. Psychiatric Institute Investigation
  • May 14, 2025
    FDA, HHS Launch Deregulation Initiative, Seek Public Input on Outdated, Unneeded Rules, Guidance
  • May 7, 2025
    Investigator Receives Warning Letter for Allegedly Not Following Exclusion Criteria
  • Apr 25, 2025
    FDA Reiterates Interest in Advancing Digital Health Technologies in Trials
  • Apr 18, 2025
    UK Updates Clinical Trial Rules
  • More

U.S. Food Labeling

  • May 30,2025
    Pa. Legislature Considers Food Labeling Bills
  • May 14,2025
    FDA, HHS Launch Deregulation Initiative, Seek Public Input on Outdated, Unneeded Rules, Guidance
  • May 9,2025
    FDA Extends Proposed FOP Rule Comment Period to July 15
  • Apr 25,2025
    FDA Moves To Remove All Petroleum-Based Dyes From Food
  • Apr 18,2025
    Menendez Reintroduces Caffeine Labeling Bill
  • Apr 16,2025
    Study Finds Meat-like Names for Plant-based Products Could Confuse Consumers
  • Mar 28,2025
    FDA Answers Questions on Food Allergen Labeling
  • Mar 27,2025
    Senate Votes To Confirm Makary as FDA Commissioner
  • Mar 4,2025
    Fig Bar Label Case Continues Over Use of ‘Wholesome’
  • Feb 24,2025
    FDA Pushes ‘Healthy’ Claim Final Rule Effective Date to April
  • More

FDA Regulation & Enforcement

  • Jan 21, 2026
    U.S. Appeals Court Affirms Certification in Class Action Suit Alleging Deceptive Labeling
  • Jan 21, 2026
    Legislation Would Streamline Device Recalls With Electronic Reporting, Mandate Patient Notifications
  • Jan 16, 2026
    OPDP Issues Untitled Letters for Branded Backgrounds, Webpages and DTC TV Ad
  • Jan 14, 2026
    Court: Some Claims Against PMA Device Maker Linked to Alleged Off-Label Promotion Survive Preemption
  • Jan 14, 2026
    Tennessee Physician Found Guilty on Device Adulteration, Misbranding and Health Care Fraud Charges
  • Jan 7, 2026
    HHS OIG Finds That Vaccine Maker’s Discounts, Rebates Pass Muster Under Anti-Kickback Statute
  • Jan 7, 2026
    Food Trade Groups Sue Texas Over Warning Label Law
  • Jan 2, 2026
    Bipartisan House Bill Would Require FOP Health Warnings
  • Dec 27, 2025
    OPDP Contends Clinical Trial Results Don’t Support Cobenfy DTC TV Ad Claims
  • Dec 23, 2025
    Newly Finalized Guidance Offers Insights on BIMO Inspections Not Provided in Agency Guides, Manuals
  • More

Medical Devices

  • Oct 8, 2025
    CDRH Sets Guidance Development Priorities for FY 2026, Reports Progress Toward Guidance Finalization
  • Oct 2, 2025
    FDA Seeks Input From Public on How To Evaluate Real-World Performance of AI-Enabled Medical Devices
  • Oct 1, 2025
    Device Firm, Distributor Settle Claims That They Misrepresented Medicare Coverage Status of Tests
  • Sep 25, 2025
    Court Dismisses Purchasers’ Claims Against Device Firm Alleged To Have Misled FDA During PMA Process
  • Sep 18, 2025
    Exactech Enters Into $8 Million Resolution of Allegations Regarding Defective Knee Implants
  • Sep 10, 2025
    AdvaMed: Device Firms’ Use of Independent Sales Agents Does Not Violate Anti-Kickback Statute
  • Sep 3, 2025
    Kimberly-Clark To Pay Up to $40.4M for Selling Modified Surgical Gowns Without New 510(k) Clearance
  • Aug 27, 2025
    AdvaMed, Other Stakeholders Call for Streamlined Pathway to Medicare Coverage for Innovative Medtech
  • Aug 21, 2025
    SpineFrontier CEO Dodges Prison Term on False Statements Charge Related to Alleged Kickback Scheme
  • Aug 20, 2025
    Citing Preemption, Court Rejects Claims Brought Against Defibrillator Maker Following Patient Death
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.